Oleacein Prevents High Fat Diet-Induced Adiposity and Ameliorates Some Biochemical Parameters of Insulin Sensitivity in Mice.
3T3-L1 Cells
Adipogenesis
/ drug effects
Adipose Tissue
/ chemistry
Adiposity
/ drug effects
Aldehydes
/ pharmacology
Animals
Anti-Obesity Agents
/ pharmacology
Biomarkers
/ analysis
Diet, High-Fat
Glucose Transporter Type 4
/ analysis
Insulin Resistance
Male
Mice
Mice, Inbred C57BL
Obesity
/ prevention & control
Phenols
/ pharmacology
Glut-4
abdominal fat
adipogenesis
high-fat diet
obesity
oleacein
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
07 08 2019
07 08 2019
Historique:
received:
26
06
2019
revised:
02
08
2019
accepted:
05
08
2019
entrez:
10
8
2019
pubmed:
10
8
2019
medline:
23
1
2020
Statut:
epublish
Résumé
Oleacein is one of the most abundant polyphenolic compounds of olive oil, which has been shown to play a protective role against several metabolic abnormalities, including dyslipidemia, insulin resistance, and glucose intolerance. Herein, we investigated the effects of oleacein on certain markers of adipogenesis and insulin-resistance in vitro, in 3T3-L1 adipocytes, and in vivo in high-fat diet (HFD)-fed mice. During the differentiation process of 3T3-L1 preadipocytes into adipocytes, oleacein strongly inhibited lipid accumulation, and decreased protein levels of peroxisome proliferator-activated receptor gamma (PPARγ) and fatty acid synthase (FAS), while increasing Adiponectin levels. In vivo, treatment with oleacein of C57BL/6JOlaHsd mice fed with HFD for 5 and 13 weeks prevented the increase in adipocyte size and reduced the inflammatory infiltration of macrophages and lymphocytes in adipose tissue. These effects were accompanied by changes in the expression of adipose tissue-specific regulatory elements such as PPARγ, FAS, sterol regulatory element-binding transcription factor-1 (SREBP-1), and Adiponectin, while the expression of insulin-sensitive muscle/fat glucose transporter Glut-4 was restored in HFD-fed mice treated with oleacein. Collectively, our findings indicate that protection against HFD-induced adiposity by oleacein in mice is mediated by the modulation of regulators of adipogenesis. Protection against HFD-induced obesity is effective in improving peripheral insulin sensitivity.
Identifiants
pubmed: 31394876
pii: nu11081829
doi: 10.3390/nu11081829
pmc: PMC6723526
pii:
doi:
Substances chimiques
Aldehydes
0
Anti-Obesity Agents
0
Biomarkers
0
Glucose Transporter Type 4
0
Phenols
0
Slc2a4 protein, mouse
0
oleacein
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
IUBMB Life. 2004 Oct;56(10):595-600
pubmed: 15814457
Nat Med. 2005 Jul;11(7):765-73
pubmed: 15924147
Biotechniques. 2007 Jul;43(1 Suppl):25-30
pubmed: 17936939
Endocr Relat Cancer. 2008 Mar;15(1):325-35
pubmed: 18310298
BMC Biol. 2009 May 21;7:24
pubmed: 19460132
Int J Mol Sci. 2010 Feb 02;11(2):458-79
pubmed: 20386648
Biotechnol J. 2010 Sep;5(9):950-60
pubmed: 20845385
J Hepatol. 2011 May;54(5):984-93
pubmed: 21145829
Sci Rep. 2012;2:251
pubmed: 22355763
Curr Med Chem. 2012;19(23):4006-13
pubmed: 22680639
Mol Endocrinol. 2012 Sep;26(9):1578-89
pubmed: 22745191
Mol Nutr Food Res. 2013 May;57(5):760-71
pubmed: 23450515
Genes Nutr. 2014 Jan;9(1):376
pubmed: 24323842
Evid Based Complement Alternat Med. 2014;2014:971890
pubmed: 24624222
J Transl Med. 2014 Aug 03;12:219
pubmed: 25086598
Mol Nutr Food Res. 2014 Nov;58(11):2166-76
pubmed: 25104077
Phytomedicine. 2015 Dec 15;22(14):1255-61
pubmed: 26655408
Int J Endocrinol. 2015;2015:431453
pubmed: 26798341
Front Endocrinol (Lausanne). 2016 May 27;7:49
pubmed: 27303363
Curr Vasc Pharmacol. 2017;15(1):30-39
pubmed: 27748199
Molecules. 2016 Dec 16;21(12):
pubmed: 27999296
World J Diabetes. 2017 Sep 15;8(9):422-428
pubmed: 28989568
Food Chem. 2018 Apr 15;245:410-414
pubmed: 29287389
Proteomics. 2018 Apr;18(7):e1700260
pubmed: 29466620
Int J Mol Sci. 2018 Feb 28;19(3):null
pubmed: 29495598
Front Endocrinol (Lausanne). 2018 Mar 19;9:116
pubmed: 29615982
J Cell Physiol. 2019 Jun;234(6):8152-8161
pubmed: 30317615
Pharmacol Res. 2019 Apr;142:77-86
pubmed: 30772463
J Clin Invest. 1993 Sep;92(3):1288-95
pubmed: 8376587
J Clin Invest. 1996 Jan 1;97(1):258-62
pubmed: 8550844